Diagnosis and staging of carcinoma of the pancreas (I);Diagnóstico y estadificación del carcinoma de páncreas (I)

Radiologia

Volumn 48, Issue 5, 2006, Pages 273-282

  Ayuso, C ^a   Sanchez M ^a   Ayuso, J R ^a   De Caralt, T M ^a   De Juan, C ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Diagnostic imaging; Echoendoscopy; Helical computed tomography; Magnetic resonance; MR cholangiopancreatography; Pancreatic duct carcinoma; Positron emission tomography; Ultrasonograf a

Indexed keywords

CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HUMAN; LAPAROSCOPY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIODIAGNOSIS; REVIEW;

EID: 33751006469     PISSN: 00338338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-8338(06)75136-0     Document Type: Article

References (81)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. 1997. CA Cancer J Clin. 1997;47:5-27.
2. Yeo TP, Hruban RH, Leach SD, Wilentz RE, Sohn TA, Kern SE, et al. Pancreatic cancer. Curr Probl Cancer. 2002;26:176-275.
3. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15-36.
4. Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin N Am. 1998;7:67-91.
5. Klein AP, Hruban RH, Brune KA, Petersen GM, Goggins M. Familial pancreatic cancer. Cancer J. 2001;7:266-73.
6. Tamm EP, Silverman PM, Charnsangavej C, Evans DB. Diagnosis, staging, and surveillance of pancreatic cancer. Am J Roentgenol. 2003;180:1311-23.
7. Ariyama J, Suyama M, Ogawa K, Ikari T, Nagaiwa J, Fujii D, et al. The detection and prognosis of small pancreatic carcinoma. Int J Pancreatol. 1990;7:37-47.
8. Matsuno S, Satake K, Sunamura M, Go VL. Advancements in Pancreatic Cancer Research in Japan and Unfolding Prospective. Pancreas. 2004;28:217-8.
9. Egawa S, Takeda K, Fukuyama S, Motoi F, Sunamura M, Matsuno S. Clinicopathological aspects of small pancreatic cancer. Pancreas. 2004;28:235-40.
10. Choe KA. Intraductal papillary mucinous tumors and mucinous cystic tumors of the pancreas: imaging. J Hepatobiliary Pancreat Surg. 2003;10:137-41.
11. Takaori K, Hruban RH, Maitra A, Tanigawa N. Pancreatic intraepithelial neoplasia. Pancreas. 2004;28:257-62.
12. Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788-97.
13. Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas. 1992;7:66-86.
14. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4: 567-79.
15. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995;221:721-31.
16. Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999;229:613-22.
17. Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA, et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg. 1995;222:580-8.
18. Clark LR, Jaffe MH, Choyke PL, Grant EG, Zeman RK. Pancreatic imaging. Radiol Clin North Am. 1985;23:489-501.
19. Miquel R. Tumores pancreáticos: Adenocarcinoma. Anatomía Patológica. En Navarro S, Pérez-Mateo M, Guarner L, editores. Tratado de Páncreas Exocrino. Barcelona: J&C Ediciones Médicas, S.L., 2002. p. 340-6.
20. Clarke DL, Thomson SR, Madiba TE, Sanyika C. Preoperative imaging of pancreatic cancer: a management-oriented approach. J Am Coll Surg. 2003;196:119-29.
21. López HE, Amthauer H, Hosten N, Ricke J, Bohmig M, Langrehr J, et al. Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. Radiology. 2002;224:34-41.
22. Angeli E, Venturini M, Vanzulli A, Sironi S, Castrucci M, Salvioni M, et al. Color Doppler imaging in the assessment of vascular involvement by pancreatic carcinoma. AJR Am J Roentgenol. 1997;168:193-7.
23. Minniti S, Bruno C, Biasiutti C, Tonel D, Falzone A, Falconi M, et al. Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma. J Clin Ultrasound. 2003;31:175-82.
24. Moossa AR, Levin B. The diagnosis of «early» pancreatic cancer: the University of Chicago experience. Cancer. 1981;47:1688-97.
25. Rosch T, Braig C, Gain T, Feuerbach S, Siewert JR, Schusdziarra V, et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology. 1992;102:188-99.
26. Balci NC, Semelka RC. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma. Eur J Radiol. 2001;38:105-12.
27. Kim T, Murakami T, Takahashi S, Okada A, Hori M, Narumi Y, et al. Pancreatic CT imaging: effects of different injection rates and doses of contrast material. Radiology. 1999;212:219-25.
28. Choi BI, Chung MJ, Han JK, Han MC, Yoon YB. Detection of pancreatic adenocarcinoma: relative value of arterial and late phases of spiral CT. Abdom Imaging. 1997;22:199-203.
29. Raptopoulos V, Steer ML, Sheiman RG, Vrachliotis TG, Gougoutas CA, Movson JS. The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: correlation with findings at surgery. AJR Am J Roentgenol. 1997;168:971-7.
30. Tabuchi T, Itoh K, Ohshio G, Kojima N, Maetani Y, Shibata T, et al. Tumor staging of pancreatic adenocarcinoma using early- and late-phase helical CT. AJR Am J Roentgenol. 1999;173:375-80.
31. Hollett MD, Jorgensen MJ, Jeffrey RB Jr. Quantitative evaluation of pancreatic enhancement during dual-phase helical CT. Radiology. 1995;195:359-61.
32. Lu DS, Vedantham S, Krasny RM, Kadell B, Berger WL, Reber HA. Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures. Radiology. 1996;199:697-701.
33. Boland GW, O'Malley ME, Sáez M, Fernández-del-Castillo C, Warshaw AL, Mueller PR. Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol. 1999;172:605-8.
34. McNulty NJ, Francis IR, Platt JF, Cohan RH, Korobkin M, Gebremariam A. Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology. 2001;220:97-102.
35. Vargas R, Nino-Murcia M, Trueblood W, Jeffrey RB Jr. MDCT in Pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol. 2004;182:419-25.
36. Prokesch RW, Schima W, Chow LC, Jeffrey RB. Multidetector CT of pancreatic adenocarcinoma: diagnostic advances and therapeutic relevance. Eur Radiol. 2003;13:2147-54.
37. Valls C, Andia E, Sánchez A, Fabregat J, Pozuelo O, Quintero JC, et al. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol. 2002;178:821-6.
38. Smith SL, Rajan PS. Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT. Clin Radiol. 2004;59:26-38.
39. Fletcher JG, Wiersema MJ, Farrell MA, Fidler JL, Burgart LJ, Koyama T, et al. Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology. 2003;229:81-90.
40. Kalra MK, Maher MM, Mueller PR, Saini S. State-of-the-art imaging of pancreatic neoplasms. Br J Radiol. 2003;76:857-65.
41. Graf O, Boland GW, Warshaw AL, Fernández-del-Castillo C, Hahn PF, Mueller PR. Arterial versus portal venous helical CT for revealing pancreatic adenocarcinoma: conspicuity of tumor and critical vascular anatomy. AJR Am J Roentgenol. 1997;169:119-23.
42. Prokesch RW, Chow LC, Beaulieu CF, Nino-Murcia M, Mindelzun RE, Bammer R, et al. Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations initial experience. Radiology. 2002;225:759-65.
43. Johnson PT, Heath DG, Hofmann LV, Horton KM, Fishman EK. Multidetector-row computed tomography with three-dimensional volume rendering of pancreatic cancer: a complete preoperative staging tool using computed tomography angiography and volume-rendered cholangiopancreatography. J Comput Assist Tomogr. 2003;27:347-53.
44. Nino-Murcia M, Tamm EP, Charnsangavej C, Jeffrey RB Jr. Multidetector-row helical CT and advanced postprocessing techniques for the evaluation of pancreatic neoplasms. Abdom Imaging. 2003;28:366-77.
45. Baek SY, Sheafor DH, Keogan MT, DeLong DM, Nelson RC. Two-dimensional multiplanar and three-dimensional volume-rendered vascular CT in pancreatic carcinoma: interobserver agreement and comparison with standard helical techniques. AJR Am J Roentgenol. 2001;176:1467-73.
46. Saisho H, Yamaguchi T. Diagnostic imaging for pancreatic cancer: computed tomography, magnetic resonance imaging, and positron emission tomography. Pancreas. 2004;28:273-8.
47. Freeny PC, Marks WM, Ryan JA, Traverse LW. Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology. 1988;166:125-33.
48. Bluemke DA, Cameron JL, Hruban RH, Pitt HA, Siegelman SS, Soyer P, et al. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology. 1995;197:381-5.
49. Laghi A, Iannaccone R, Catalane C, Carbone I, Sansoni I, Mangiapane F, et al. Multislice spiral computed tomography ni diagnosis and staging of pancreatic carcinoma: preliminary experience. Dig Liver ver Dis. 2002;34:732-8.
50. Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology. 2002;224:764-8.
51. Bronstein YL, Lover EM, Kaur H, Choi H, David C, DuBrow RA, et al. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol. 2004;182:619-23.
52. Kim T, Murakami T, Takamura M, Hori M, Takahashi S, Nakamori S. et al. Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol. 2001;177:367-71.
53. Warshaw AL, Gu ZY, Wittenberg J, Waltman AC. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Sure. 1990;125:230-3.
54. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Ohtomo K, Kinoshita T. et al. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology. 1997;202:655-62.
55. Irie H, Honda H, Kaneko K, Kuroiwa T, Yoshimitsu K, Masuda K. Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma. Abdom Imaging. 1997;22:429-33.
56. Semelka RC, Kelekis NL, Molina PL, Sharp TJ, Calvo B. Pancreatic masses with inconclusive findings on spiral CT: is there a role for MRI? J Magn Reson Imaging. 1996;6:585-8.
57. Nishiharu T, Yamashita Y, Abe Y, Mitsuzaki K, Tsuchigame T, Nakayama Y, et al. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging-ROC analysis. Radiology. 1999;212:445-52.
58. Sheridan MB, Ward J, Guthrie JA, Spencer JA, Craven CM, Wilson D, et al. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis. AJR Am J Roentgenol. 1999;173:583-90.
59. Ayuso JR. Técnicas de imagen. Resonancia Magnética. En: Navarro S. Pérez-Mateo M, Guarner L, editores. Tratado de Páncreas Exocrino. Barcelona: J&C Ediciones Médicas. S.L., 2002. p. 69-76.
60. Martin DR. Semelka RC. MR imaging of pancreatic masses. Magn Reson Imaging Clin N Am. 2000;8:787-812.
61. Robinson PA. The role of MRI in pancreatic cancer. Eur Radiol. 2002;12:267-9.
62. Gabata T, Matsui O, Kadoya M, Yoshikawa J, Miyayama S, Takashima T, et al. Small pancreatic adenocarcinomas: efficacy of MR imaging with fat suppression and gadolinium enhancement. Radiology. 1994;193:683-8.
63. Romijn MG, Stoker J, van Eijck CH, van Muiswinkel JM, Torres CG, Lameris JS. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer. J Magn Reson Imaging. 2000;12:261-8.
64. Kettritz U, Warshauer DM, Brown ED, Schlund JF, Eisenberg LB, Semelka RC. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. Eur Radiol. 1996;6:14-8.
65. Freeny PC, Bilbao MK, Katon RM. «Blind» evaluation of endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of pancreatic carcinoma: the «double duct» and other signs. Radiology. 1976;119:271-4.
66. Fulcher AS, Turner MA. MR pancreatography: a useful tool for evaluating pancreatic disorders. Radiographics. 1999;19:5-24.
67. Fujita N, Noda Y, Kobayashi G, Kimura K, Ito K. Endoscopic approach to carh diagnosis of pancreatic cancer. Pancreas. 2004;28:279-81.
68. Ichikawa T, Sou H, Araki T, Arbab AS, Yoshikawa T, Ishigame K, et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology. 2001;221:107-16.
69. Czako L, Takacs T, Morvay Z, Csernay L, Lonovics J. Diagnostic role of secretin-enhanced MRCP in patients with unsuccessful ERCP. World J Gastroenterol. 2004;10:3034-8.
70. Punwani S, Gillams AR, Lees WR. Non-invasive quantification of pancreatic exocrine function using secretin-stimulated MRCP. Eur Radiol. 2003;13:273-6.
71. Brice J. Secretin stimulation enhances diagnostic picture of MRCP. Diagn Imaging (San Franc). 1999;Supl:IR36-7.
72. Ginés A, Soria MT, Solé M, Bordas JM. Técnicas de imagen. Ultrasonografía endoscópica. En: Navarro S, Pérez-Mateo M, Guarner L. editores. Tratado de Páncreas Exocrino. Barcelona: J&C Ediciones Médicas, S.E., 2002. p. 89-98.
73. Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology. 1994;190:745-51.
74. Legmann P, Vignaux O, Dousset B, Baraza AJ, Palazzo L, Dumontier I, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol. 1998;170:1315-22
75. Dewitt J, Devereaux B, Chriswell M, McGreevy K, Howard T, Imperiale TF, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med. 2004;141:753-63.
76. Williams DB, Sahai AV, Aabakken L, Penman ID, van Velse A. Webb J, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut. 1999;44:720-6.
77. Zimny M, Schumpelick V. Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions. Chirurg. 2001;72:989-94.
78. Nitzsche EU, Hoegerle S, Mix M, Brink I, Otte A, Moser E, et al. Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis? Eur J Nucl Med Mol Imaging. 2002;29:237-42.
79. l8F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer. 2000;89:2547-54.
80. Higashi T, Saga T, Nakamoto Y, Ishimori T, Fujimoto K, Doi R, et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) - usefulness and limitations in «clinical reality». Ann Nucl Med. 2003;17:261-79.
81. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369-79.